Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.84
CAH's Cash to Debt is ranked higher than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.71 vs. CAH: 0.84 )
Ranked among companies with meaningful Cash to Debt only.
CAH' s 10-Year Cash to Debt Range
Min: 0.15  Med: 0.59 Max: 1.29
Current: 0.84
0.15
1.29
Equity to Asset 0.21
CAH's Equity to Asset is ranked lower than
78% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.43 vs. CAH: 0.21 )
Ranked among companies with meaningful Equity to Asset only.
CAH' s 10-Year Equity to Asset Range
Min: 0.21  Med: 0.36 Max: 0.43
Current: 0.21
0.21
0.43
F-Score: 7
Z-Score: 4.74
M-Score: -2.53
WACC vs ROIC
5.32%
18.10%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 2.11
CAH's Operating margin (%) is ranked lower than
61% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.04 vs. CAH: 2.11 )
Ranked among companies with meaningful Operating margin (%) only.
CAH' s 10-Year Operating margin (%) Range
Min: 0.99  Med: 2.39 Max: 4.15
Current: 2.11
0.99
4.15
Net-margin (%) 1.19
CAH's Net-margin (%) is ranked lower than
66% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.85 vs. CAH: 1.19 )
Ranked among companies with meaningful Net-margin (%) only.
CAH' s 10-Year Net-margin (%) Range
Min: 0.33  Med: 1.44 Max: 2.42
Current: 1.19
0.33
2.42
ROE (%) 19.36
CAH's ROE (%) is ranked higher than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.65 vs. CAH: 19.36 )
Ranked among companies with meaningful ROE (%) only.
CAH' s 10-Year ROE (%) Range
Min: 5.47  Med: 17.68 Max: 28.25
Current: 19.36
5.47
28.25
ROA (%) 4.43
CAH's ROA (%) is ranked higher than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.31 vs. CAH: 4.43 )
Ranked among companies with meaningful ROA (%) only.
CAH' s 10-Year ROA (%) Range
Min: 1.33  Med: 5.58 Max: 11.32
Current: 4.43
1.33
11.32
ROC (Joel Greenblatt) (%) 107.82
CAH's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.30 vs. CAH: 107.82 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CAH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 19.02  Med: 36.12 Max: 111.5
Current: 107.82
19.02
111.5
Revenue Growth (3Y)(%) -0.20
CAH's Revenue Growth (3Y)(%) is ranked lower than
81% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.80 vs. CAH: -0.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CAH' s 10-Year Revenue Growth (3Y)(%) Range
Min: -3.2  Med: 13.20 Max: 27
Current: -0.2
-3.2
27
EBITDA Growth (3Y)(%) 8.70
CAH's EBITDA Growth (3Y)(%) is ranked lower than
52% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. CAH: 8.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CAH' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -11.7  Med: 9.40 Max: 30
Current: 8.7
-11.7
30
EPS Growth (3Y)(%) 5.70
CAH's EPS Growth (3Y)(%) is ranked lower than
60% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. CAH: 5.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CAH' s 10-Year EPS Growth (3Y)(%) Range
Min: -15.7  Med: 7.10 Max: 30.9
Current: 5.7
-15.7
30.9
» CAH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

CAH Guru Trades in Q3 2014

Steven Cohen 50,900 sh (New)
Paul Tudor Jones 75,000 sh (+718.87%)
John Buckingham 18,793 sh (+3.40%)
James Barrow 6,690,760 sh (+1.05%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Pioneer Investments 2,436,448 sh (unchged)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Ray Dalio Sold Out
John Keeley 144,477 sh (-0.98%)
RS Investment Management 354,064 sh (-4.91%)
Joel Greenblatt 353,619 sh (-48.00%)
» More
Q4 2014

CAH Guru Trades in Q4 2014

Steven Cohen 58,000 sh (+13.95%)
Pioneer Investments 2,639,786 sh (+8.35%)
James Barrow 6,744,417 sh (+0.80%)
RS Investment Management 355,279 sh (+0.34%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
John Buckingham 18,396 sh (-2.11%)
John Keeley 124,297 sh (-13.97%)
Joel Greenblatt 243,387 sh (-31.17%)
Paul Tudor Jones 5,396 sh (-92.81%)
» More
Q1 2015

CAH Guru Trades in Q1 2015

Jeremy Grantham 2,400 sh (New)
Ray Dalio 70,000 sh (New)
Paul Tudor Jones 264,086 sh (+4794.11%)
Steven Cohen 105,300 sh (+81.55%)
Pioneer Investments 3,090,940 sh (+17.09%)
John Keeley 124,467 sh (+0.14%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Joel Greenblatt 235,517 sh (-3.23%)
John Buckingham 17,710 sh (-3.73%)
James Barrow 6,465,936 sh (-4.13%)
RS Investment Management 309,639 sh (-12.85%)
» More
Q2 2015

CAH Guru Trades in Q2 2015

Ray Dalio 109,300 sh (+56.14%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Jeremy Grantham Sold Out
Steven Cohen Sold Out
James Barrow 6,389,140 sh (-1.19%)
John Keeley 122,412 sh (-1.65%)
RS Investment Management 285,699 sh (-7.73%)
RS Investment Management 285,699 sh (-7.73%)
Pioneer Investments 2,732,113 sh (-11.61%)
Joel Greenblatt 201,203 sh (-14.57%)
John Buckingham 13,147 sh (-25.77%)
Paul Tudor Jones 18,997 sh (-92.81%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Cardinal Health Inc

Weekly CEO Sells Highlight: Cardinal Health Inc, Bank of the Ozarks Inc, Walt Disney Co, CBIZ Inc.
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Cardinal Health Inc, Bank of the Ozarks Inc, Walt Disney Co, CBIZ Inc. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 23.00
CAH's P/E(ttm) is ranked lower than
52% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.20 vs. CAH: 23.00 )
Ranked among companies with meaningful P/E(ttm) only.
CAH' s 10-Year P/E(ttm) Range
Min: 6.28  Med: 15.20 Max: 73.63
Current: 23
6.28
73.63
Forward P/E 16.98
CAH's Forward P/E is ranked higher than
58% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.61 vs. CAH: 16.98 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 23.10
CAH's PE(NRI) is ranked higher than
52% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.30 vs. CAH: 23.10 )
Ranked among companies with meaningful PE(NRI) only.
CAH' s 10-Year PE(NRI) Range
Min: 6.72  Med: 17.05 Max: 74.54
Current: 23.1
6.72
74.54
P/B 4.41
CAH's P/B is ranked lower than
72% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. CAH: 4.41 )
Ranked among companies with meaningful P/B only.
CAH' s 10-Year P/B Range
Min: 0.86  Med: 2.33 Max: 4.76
Current: 4.41
0.86
4.76
P/S 0.27
CAH's P/S is ranked higher than
79% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.06 vs. CAH: 0.27 )
Ranked among companies with meaningful P/S only.
CAH' s 10-Year P/S Range
Min: 0.08  Med: 0.17 Max: 0.32
Current: 0.27
0.08
0.32
PFCF 12.43
CAH's PFCF is ranked higher than
83% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.16 vs. CAH: 12.43 )
Ranked among companies with meaningful PFCF only.
CAH' s 10-Year PFCF Range
Min: 4.13  Med: 11.63 Max: 32.08
Current: 12.43
4.13
32.08
POCF 10.96
CAH's POCF is ranked higher than
78% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.72 vs. CAH: 10.96 )
Ranked among companies with meaningful POCF only.
CAH' s 10-Year POCF Range
Min: 3.59  Med: 9.76 Max: 19.56
Current: 10.96
3.59
19.56
EV-to-EBIT 12.99
CAH's EV-to-EBIT is ranked higher than
65% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.08 vs. CAH: 12.99 )
Ranked among companies with meaningful EV-to-EBIT only.
CAH' s 10-Year EV-to-EBIT Range
Min: 5.6  Med: 10.40 Max: 25.5
Current: 12.99
5.6
25.5
PEG 2.33
CAH's PEG is ranked lower than
52% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.72 vs. CAH: 2.33 )
Ranked among companies with meaningful PEG only.
CAH' s 10-Year PEG Range
Min: 0.51  Med: 6.11 Max: 101
Current: 2.33
0.51
101
Shiller P/E 30.96
CAH's Shiller P/E is ranked lower than
54% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.69 vs. CAH: 30.96 )
Ranked among companies with meaningful Shiller P/E only.
CAH' s 10-Year Shiller P/E Range
Min: 5.96  Med: 13.66 Max: 34.35
Current: 30.96
5.96
34.35
Current Ratio 1.26
CAH's Current Ratio is ranked lower than
78% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.61 vs. CAH: 1.26 )
Ranked among companies with meaningful Current Ratio only.
CAH' s 10-Year Current Ratio Range
Min: 1.19  Med: 1.41 Max: 1.81
Current: 1.26
1.19
1.81
Quick Ratio 0.73
CAH's Quick Ratio is ranked lower than
83% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.11 vs. CAH: 0.73 )
Ranked among companies with meaningful Quick Ratio only.
CAH' s 10-Year Quick Ratio Range
Min: 0.6  Med: 0.70 Max: 1.15
Current: 0.73
0.6
1.15
Days Inventory 33.26
CAH's Days Inventory is ranked higher than
67% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 50.52 vs. CAH: 33.26 )
Ranked among companies with meaningful Days Inventory only.
CAH' s 10-Year Days Inventory Range
Min: 25.37  Med: 35.34 Max: 52.89
Current: 33.26
25.37
52.89
Days Sales Outstanding 23.22
CAH's Days Sales Outstanding is ranked higher than
81% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.91 vs. CAH: 23.22 )
Ranked among companies with meaningful Days Sales Outstanding only.
CAH' s 10-Year Days Sales Outstanding Range
Min: 13.34  Med: 19.92 Max: 24.87
Current: 23.22
13.34
24.87

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.70
CAH's Dividend Yield is ranked higher than
57% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.69 vs. CAH: 1.70 )
Ranked among companies with meaningful Dividend Yield only.
CAH' s 10-Year Dividend Yield Range
Min: 0.28  Med: 1.75 Max: 2.66
Current: 1.7
0.28
2.66
Dividend Payout 0.39
CAH's Dividend Payout is ranked lower than
57% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.35 vs. CAH: 0.39 )
Ranked among companies with meaningful Dividend Payout only.
CAH' s 10-Year Dividend Payout Range
Min: 0.04  Med: 0.08 Max: 1.12
Current: 0.39
0.04
1.12
Dividend growth (3y) 17.00
CAH's Dividend growth (3y) is ranked higher than
53% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.00 vs. CAH: 17.00 )
Ranked among companies with meaningful Dividend growth (3y) only.
CAH' s 10-Year Dividend growth (3y) Range
Min: 12.2  Med: 17.00 Max: 49.4
Current: 17
12.2
49.4
Yield on cost (5-Year) 3.41
CAH's Yield on cost (5-Year) is ranked higher than
57% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.64 vs. CAH: 3.41 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CAH' s 10-Year Yield on cost (5-Year) Range
Min: 0.57  Med: 3.54 Max: 5.37
Current: 3.41
0.57
5.37
Share Buyback Rate 1.40
CAH's Share Buyback Rate is ranked higher than
77% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.60 vs. CAH: 1.40 )
Ranked among companies with meaningful Share Buyback Rate only.
CAH' s 10-Year Share Buyback Rate Range
Min: 5.8  Med: 1.30 Max: -22.9
Current: 1.4

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 115.82
CAH's Price/Tangible Book is ranked lower than
100% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.06 vs. CAH: 115.82 )
Ranked among companies with meaningful Price/Tangible Book only.
CAH' s 10-Year Price/Tangible Book Range
Min: 1.21  Med: 4.75 Max: 116.18
Current: 115.82
1.21
116.18
Price/Projected FCF 1.34
CAH's Price/Projected FCF is ranked higher than
55% of the 22 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.37 vs. CAH: 1.34 )
Ranked among companies with meaningful Price/Projected FCF only.
CAH' s 10-Year Price/Projected FCF Range
Min: 0.31  Med: 0.97 Max: 5.4
Current: 1.34
0.31
5.4
Price/Median PS Value 1.60
CAH's Price/Median PS Value is ranked lower than
78% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.07 vs. CAH: 1.60 )
Ranked among companies with meaningful Price/Median PS Value only.
CAH' s 10-Year Price/Median PS Value Range
Min: 0.49  Med: 1.57 Max: 3.37
Current: 1.6
0.49
3.37
Price/Peter Lynch Fair Value 4.14
CAH's Price/Peter Lynch Fair Value is ranked lower than
100% of the 14 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. CAH: 4.14 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CAH' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.71  Med: 1.13 Max: 4.15
Current: 4.14
0.71
4.15
Price/Graham Number 10.83
CAH's Price/Graham Number is ranked lower than
96% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. CAH: 10.83 )
Ranked among companies with meaningful Price/Graham Number only.
CAH' s 10-Year Price/Graham Number Range
Min: 0.75  Med: 2.06 Max: 10.86
Current: 10.83
0.75
10.86
Earnings Yield (Greenblatt) (%) 7.70
CAH's Earnings Yield (Greenblatt) (%) is ranked higher than
72% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.80 vs. CAH: 7.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CAH' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.9  Med: 9.60 Max: 17.9
Current: 7.7
3.9
17.9
Forward Rate of Return (Yacktman) (%) 11.23
CAH's Forward Rate of Return (Yacktman) (%) is ranked lower than
54% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.35 vs. CAH: 11.23 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CAH' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 3.9  Med: 9.80 Max: 25.4
Current: 11.23
3.9
25.4

Analyst Estimate

Jun16 Jun17 Jun18
Revenue(Mil) 108,721 119,175 127,639
EPS($) 4.91 5.63 6.49
EPS without NRI($) 4.91 5.63 6.49

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, SHTDF, HSIC, PDCO » details
Traded in other countries:CLH.Germany,
Cardinal Health Inc is an Ohio corporation formed in 1979. The Company along with its subsidiaries is a healthcare services company providing pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The Company also provides medical products to patients in the home. The Company operates in two segments; Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers. This segment renders services to pharmaceutical manufacturers including distribution, inventory management, data reporting, and new product launch support; provides pharmacy services to hospitals and other healthcare facilities; and franchises retail pharmacies under the Medicine Shoppe and Medicap brands. It also operates nuclear pharmacies and cyclotron facilities through its Nuclear Pharmacy Services division that manufacture, prepare and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; and distributes specialty pharmaceutical products, provides services to pharmaceutical manufacturers, third-party payors and healthcare providers supporting the development, marketing, distribution and payment for specialty pharmaceutical products, and operates specialty pharmacies through its Specialty Solutions division. The Medical segment distributes a broad range of medical, surgical and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers in the United States, Canada and China and to patients in the home in the United States through its Cardinal Health at Home division. It also manufactures sources and develops its line of private brand medical and surgical products. Manufactured products include: single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems. The Medical segment also assembles and offers sterile and non-sterile procedure kits. Its manufactured products are sold directly or through third-party distributors in the United States, Canada, Europe and other regions internationally. In addition, the segment provides supply chain services, including spend management, distribution management and inventory management services, to healthcare providers. The Company's Pharmaceutical segment competes with wholesale distributors with national reach including McKesson Corporation and AmerisourceBergen Corporation, regional wholesale distributors, self-warehousing chains, specialty distributors, third-party logistics companies, companies that provide services supporting the development, marketing, distributio
» More Articles for CAH

Headlines

Articles On GuruFocus.com
The Case for Investing in AmerisourceBergen Aug 13 2015 
Weekly CEO Sells Highlight: Cardinal Health Inc, Bank of the Ozarks Inc, Walt Disney Co, CBIZ Inc. May 17 2015 
Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015 
My Stocks Mar 06 2015 
Johnson & Johnson Has A Potential Buyer For Its Medical Devices Unit Feb 24 2015 
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Dividend Aristocrats In Focus Part 26 of 54: Walgreens Oct 23 2014 
Dividend Aristocrats In Focus Part 20 of 54: Cardinal Health Oct 16 2014 
AmerisourceBergen Is a Center Piece in the Pharma Industry Sep 30 2014 

More From Other Websites
Cardinal Health buys company helping hospitals save on Medicare claims Aug 25 2015
CARDINAL HEALTH INC Financials Aug 19 2015
10-K for Cardinal Health, Inc. Aug 15 2015
New Cloud-Based Automation and Analytics Solutions Help Hospitals Remove Cost from Operating Room... Aug 14 2015
The Case for Investing in AmerisourceBergen Aug 13 2015
Oriola-KD Oyj Earnings Q2*, 2015 Aug 12 2015
Dublin buildings in Blackstone deal much fuller after flurry of leases Aug 11 2015
CARDINAL HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 06 2015
Cardinal Health Board of Directors Approves Quarterly Dividend Aug 05 2015
Cardinal Health Board of Directors Approves Quarterly Dividend Aug 05 2015
Edited Transcript of CAH earnings conference call or presentation 30-Jul-15 12:30pm GMT Jul 30 2015
Cardinal Health (CAH) Earnings Report: Q4 2015 Conference Call Transcript Jul 30 2015
Cardinal Health Beats Q4 Earnings on Higher Revenues - Analyst Blog Jul 30 2015
Will Cardinal Health (CAH) Stock be Helped by Earnings Beat? Jul 30 2015
Early movers: PG, CI, SWK, TSLA, FB, WFM & more Jul 30 2015
Cardinal Health (CAH) Beats on Q4 Earnings & Revenues - Tale of the Tape Jul 30 2015
Cardinal Health Profit Rises 26% Jul 30 2015
Cardinal tops Street 4Q forecasts Jul 30 2015
Cardinal tops Street 4Q forecasts Jul 30 2015
Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results Jul 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK